---
title: "Explainable ML Predicts Cognitive Decline and Postural Instability in Early Parkinson’s Disease"
id: "medrxiv-6-explainable-machine-learning-identifies-predictors-for-postural-instability-and"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-6-explainable-machine-learning-identifies-predictors-for-postural-instability-and"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1?rss=1"
published_at: "2026-10-05T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Explainable ML Predicts Cognitive Decline and Postural Instability in Early Parkinson’s Disease
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-6-explainable-machine-learning-identifies-predictors-for-postural-instability-and
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1?rss=1)
- **Published At:** 2026-10-05T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study applied an interpretable machine learning method, **Explainable Boosting Machines (EBM)**, to predict progression to **mild cognitive impairment (MCI)** and **postural instability (PI)** in early **Parkinson’s disease (PD)**. - Two independent cohorts of early PD patients were used, combining large multimodal datasets to derive and test predictive models. - Models were trained using a **minimal clinico-demographic dataset** and an **extended multimodal dataset** that included volumetric brain imaging and fluid biomarkers. - Predictive performance of EBMs using the minimal dataset was reported as comparable to that achieved with the extended multimodal dataset. - Across models built on the minimal dataset, **baseline age** and **Montreal Cognitive Assessment (MoCA) total score** emerged as the most important predictors for both MCI and PI. - The extended dataset models identified additional motor, cognitive, and imaging features as relevant predictors beyond age and baseline cognition. - The authors emphasize the potential for individualized ML predictions of cognitive and motor outcomes in PD to support personalized clinical decision-making. - Data availability: TuePaC cohort data are available on request from the corresponding author; PPMI data were downloaded from the PPMI database on January 27, 2023. The study code is available at the linked GitHub repository (https://github.com/meDIC-UKT/LOC-PD). - Ethical oversight: the study was approved by the Ethics Committee of the University of Tuebingen and patient consent procedures were followed. - The manuscript is a medRxiv clinical preprint posted October 05, 2026. Funding and competing interests from multiple authors are declared in the source; specific disclosures are listed by author in the original report.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=nZeWCiv_MB8RB0ONBIFF_f3N31TO8ch0CoVE6y4v7OI-1791243681.1039548-1.2.1.1-PsQ75QB3DgYewglyQbMEcVI1ug8yv4E1dPG77c6mWjS1Ndr5BOsxJximHT._fkB_) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Explainable machine learning identifies predictors for postural instability and cognitive impairment in early Parkinsons Disease Benjamin Sailer, [ View ORCID Profile](http://orcid.org/0000-0002-4905-8698)Benjamin Roeben, Christoph Kiefer, Lars-Christian Achauer, Roswitha Kemmner, Isabel Wurster, Stefanie Lerche, Benjamin Bender, Tobias Lindig, Claudia Schulte, Christian Deuschle, Christian Erhardt, Thomas Gasser, Kathrin Brockmann, Oliver Kohlbacher, Stefanie Biergans, Inga Liepelt-Scarfone doi: https://doi.org/10.64898/2026.09.30.26364120 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Benjamin Sailer University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Benjamin%2BSailer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sailer%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABenjamin%2BSailer%2B) Benjamin Roeben University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Benjamin%2BRoeben%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Roeben%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABenjamin%2BRoeben%2B) * [ORCID record for Benjamin Roeben](http://orcid.org/0000-0002-4905-8698 "Open in new tab") * For correspondence: benjamin.roeben@med.uni-tuebingen.de Christoph Kiefer University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christoph%2BKiefer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kiefer%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristoph%2BKiefer%2B) Lars-Christian Achauer University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lars-Christian%2BAchauer%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Achauer%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALars-Christian%2BAchauer%2B) Roswitha Kemmner University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Roswitha%2BKemmner%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kemmner%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARoswitha%2BKemmner%2B) Isabel Wurster University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Isabel%2BWurster%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Wurster%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIsabel%2BWurster%2B) Stefanie Lerche University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stefanie%2BLerche%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lerche%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AStefanie%2BLerche%2B) Benjamin Bender University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Benjamin%2BBender%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bender%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABenjamin%2BBender%2B) Tobias Lindig University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tobias%2BLindig%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lindig%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATobias%2BLindig%2B) Claudia Schulte University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Claudia%2BSchulte%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Schulte%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AClaudia%2BSchulte%2B) Christian Deuschle University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christian%2BDeuschle%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Deuschle%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristian%2BDeuschle%2B) Christian Erhardt University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christian%2BErhardt%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Erhardt%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristian%2BErhardt%2B) Thomas Gasser University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Thomas%2BGasser%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Gasser%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AThomas%2BGasser%2B) Kathrin Brockmann University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kathrin%2BBrockmann%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Brockmann%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKathrin%2BBrockmann%2B) Oliver Kohlbacher University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Oliver%2BKohlbacher%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kohlbacher%20O&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AOliver%2BKohlbacher%2B) Stefanie Biergans University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stefanie%2BBiergans%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Biergans%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AStefanie%2BBiergans%2B) Inga Liepelt-Scarfone University of Tuebingen * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Inga%2BLiepelt-Scarfone%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Liepelt-Scarfone%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AInga%2BLiepelt-Scarfone%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1314067/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1314067/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1314067/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1314067/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1314067/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1314067/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Parkinsons disease (PD) exhibits considerable variability in symptom onset, severity, and clinical trajectories, making prediction of individual disease progression a complex challenge. Leveraging large multimodal datasets from two independent cohorts of early PD patients, we examined predictive features for progression to mild cognitive impairment (MCI) and postural instability (PI) using Explainable Boosting Machines (EBM) - an interpretable machine learning (ML) approach. We found comparable predictive performances of EBM models using a minimal clinico-demographic dataset compared to an extended multimodal dataset including volumetric brain imaging and fluid biomarkers. Baseline age and Montreal Cognitive Assessment total score were identified as most important predictive features for both MCI and PI using the minimal dataset, while additional motor, cognitive and imaging features were identified using the extended dataset. Our study highlights the potential of ML predictions of cognitive and motor endpoints of PD progression at the individual level bringing personalized clinical decision-making within reach. ### Competing Interest Statement B.S. has nothing to disclose. B.R. was supported by the Clinician Scientist program of the Medical Faculty of the University of Tuebingen (grant #478-0-0). He has received or receives funding from the Michael J. Fox Foundation for Parkinsons Research. C.K. is employed by Personalens. L.A. has nothing to disclose. I.W. received funding from the Michael J. Fox Foundation in form of the Edmond J. Safra Fellowship in Movement Disorders. R.K. has nothing to disclose. S.L. has nothing to disclose. B.B. received speaker honoraria by Eisai GmbH and Medtronic, both outside the submitted work. He serves as CTO and share-holder of AIRAmed GmbH. T.L. received speaker honoraria by Eisai GmbH. He serves as CEO and share-holder of AIRAmed GmbH. C.S. has nothing to disclose. C.D. has nothing to disclose. C.E. has nothing to disclose. T.G. serves on the editorial board of the Journal of Parkinsons disease. He holds a patent re: KASPP (LRRK2) Gene, its Production and Use for the Detection and Treatment of Neurodegenerative Diseases. He has received speaker honoraria from UCB Pharma, Novartis, Sanofi, and MedUpdate. He has received consulting fees from Bayer AG, BlueRock Therapeutics, and Biogen. He is Chairman of the Scientific Advisory Board of the Joint Programming for Neurodegenerative Diseases program, funded by the European Commission. He has received grant support from the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), the Ministry of Science, Research and Art Baden-Wuerttemberg (MWK), the European Commission, the Helmholtz Association, and the Michael J. Fox Foundation. K.B. has received or receives funding from the Michael J. Fox Foundation for Parkinsons Research, the German Society of Parkinsons disease (DPG), the Health Forum Baden Wuerttemberg, the Else Kroener Fresenius Foundation, the University of Tuebingen, and from the German Research Foundation (DFG). She serves as a consultant for F. Hoffman-La Roche Ltd., Vanqua Bio, and the Michael J. Fox Foundation for Parkinsons Research and has received speaker honoraria form Abbvie, Lundbeck, UCB and Zambon. O.K. has nothing to disclose. S.B. has nothing to disclose. I.L.-S. has received grants from Janssen Research and Development, a division of Janssen Pharmaceutica N.V. and grants from the Michael J. Fox Foundation; grants from European Commission, H2020-TWINN-2015, International Parkinson Fonds (Deutschland) GmbH (IPD), Novartis and German Ministry for Education and Research (BMBF), Parkinson Stiftung not related to the reported project. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by the Ethics Committee of the University of Tuebingen. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Data of this study including data from the TuePaC cohort are available upon request to the corresponding author. Data from the PPMI study used in the present study were downloaded on January 27, 2023 from the PPMI database (www.ppmi-info.org/data). The code programmed for and used in this study is accessible in the following GitHub repository: https://github.com/meDIC-UKT/LOC-PD. ## Funder Information Declared Bundesministerium für Forschung, Technologie und Raumfahrt, https://ror.org/04pz7b180, 01ZZ1804[A I] Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.29.26364296v1 "An insight into birthing and EmONC service utilisation for making birthing safe: a qualitative study in underdeveloped districts of Punjab, Pakistan.")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.30.26364074v1 "Quantitative Fetal Hemoglobin Measurement: GazelleTM Point-of-Care Electrophoresis versus Standard HPLC Methodology") Posted October 05, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/05/2026.09.30.26364120.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.09.30.26364120v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/05/2026.09.30.26364120.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Explainable machine learning identifies predictors for postural instability and cognitive impairment in early Parkinsons Disease Benjamin Sailer, Benjamin Roeben, Christoph Kiefer, Lars-Christian Achauer, Roswitha Kemmner, Isabel Wurster, Stefanie Lerche, Benjamin Bender, Tobias Lindig, Claudia Schulte, Christian Deuschle, Christian Erhardt, Thomas Gasser, Kathrin Brockmann, Oliver Kohlbacher, Stefanie Biergans, Inga Liepelt-Scarfone medRxiv 2026.09.30.26364120; doi: https://doi.org/10.64898/2026.09.30.26364120 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.30.26364120v1%26text%3DExplainable%2520machine%2520learning%2520ide
## Related Clinical Research

- [Mitochondrial dysfunction in neurology: biomarkers for diagnosis, stratification and monitoring](https://medichelpline.com/clinical-feed/nature-reviews-neurology-0-mitochondrial-dysfunction-in-neurology-biomarkers-and-clinical-implications.md)
- [Multiscale mapping links cortical reorganization and astrogliosis to memory loss after traumatic b](https://medichelpline.com/clinical-feed/biorxiv-4-aberrant-cortical-reorganization-and-astrogliosis-underlie-memory-deficit-post.md)
- [Chromatin signatures determine diurnal gene expression timing in the Drosophila retina](https://medichelpline.com/clinical-feed/biorxiv-5-chromatin-states-coordinate-diurnal-gene-expression-in-the-drosophila-retina.md)
- [Single Plasma Proteomic Panel Classifies Alzheimer, Parkinson, and ALS with High Internal Accuracy](https://medichelpline.com/clinical-feed/medrxiv-1-plasma-proteomic-classification-of-alzheimer-disease-parkinson-disease-and.md)
- [Sensorimotor cortex beta activity during cued gait differs in Parkinson’s freezers and non-freezers](https://medichelpline.com/clinical-feed/medrxiv-2-sensorimotor-cortex-activity-during-cued-gait-differs-in-parkinson-s-freezers.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.